Perspectivetherapeuticsincis A Clinical Stageradiopharmaceutical Development Company Based In Seattlewashingtonthecompany Focuses On Creating Advanced Treatments For Various Cancers And Is Listed On Thenyseamerican Exchangeunder Theticker Symbol Catxthecompany Specializes In Developing Radiopharmaceuticals And Imaging Diagnostics Using Its Proprietary Technology That Employs Thealpha Emitting Isotope212 Pbthis Technology Aims To Deliver Targeted Radiation To Cancer Cellsenhancing Treatment Efficacy Whileminimizing Toxicitykey Programs Includevmt01 For Metastatic Melanomavmt Inet For Neuroendocrinetumorsand Psv 59 Targeting Fap Iin Solid Tumorsall Currently In Clinical Trialsperspectivetherapeutics Is Also Expanding Its Manufacturing Capabilities To Support Clinical Trials And Futurecommercial Operationsas Of December 12024Thecompany Reported Approximately $227 Million In Cash And Investments To Fund Its Clinical Milestones And Operations
No conferences found for this company.
| Company Name | Isoray Medical Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
